SARIFA-status, BRAF, RAS, and DNA mismatch repair (﻿MMR) status were available for 1726 CRC patients from the prospective Netherlands Cohort Study (NLCS, 1986–2006). This evidence concerns the gene BRAF and colorectal carcinoma.